A new therapy for drug-resistant malaria using Plasmodium synthetic lethality inference
نویسندگان
چکیده
منابع مشابه
New emerging drug-resistant malaria
CLINICAL QUESTION What is the best treatment for artemisinin-resistant malaria? RESULTS There is still no better treatment than the presently used artemisinin-based combination therapies. A new antimalarial drug for this problem needs to be found. IMPLEMENTATION Pitfalls to avoid when treating drug-resistant malaria:
متن کاملSynthetic lethality--a new direction in cancer-drug development.
In this issue of the Journal, Fong et al. report the results of a phase 1 trial of a new cancer therapy involving 60 patients (ClinicalTrials.gov number, NCT00516373).1 Readers may be surprised by the editors’ decision to publish a small early-stage trial, but this trial not only reports important results — it also points to a new direction in the development of anticancer drugs. Modern cancerd...
متن کاملClearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria.
Residents of malaria-endemic areas sometimes spontaneously clear Plasmodium falciparum infection without drug treatment, implying an important role for host factors such as immunity in this clearance. Host factors may also contribute to clearance of parasites resistant to a treatment drug. Chloroquine resistance is caused by point mutations in P. falciparum chloroquine resistance transporter (p...
متن کاملCombating multidrug‐resistant Plasmodium falciparum malaria
Over the past 50 years, Plasmodium falciparum has developed resistance against all antimalarial drugs used against it: chloroquine, sulphadoxine-pyrimethamine, quinine, piperaquine and mefloquine. More recently, resistance to the artemisinin derivatives and the resulting failure of artemisinin-based combination therapy (ACT) are threatening all major gains made in malaria control. Each time res...
متن کاملProposal for a synthetic lethality therapy using the paralog dependence of cancer cells--response.
We thank Dr. Thompson and colleagues for their insightful comments about our article (1). We have now reevaluated our finding based on their comments. Recently, two studies sought to identify synthetic lethal partners for BRG1 using the same (and other) cancer cell lines as used by us (2, 3); their conclusions were in agreement with our own. Hoffman and colleagues (2) used a deepcoverage design...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Malaria Journal
سال: 2012
ISSN: 1475-2875
DOI: 10.1186/1475-2875-11-s1-p61